Synopsis:
Reflects current rules, regulations, and guidelines in Title 21 of the Code of Federal Regulations and presents the latest advances in expediting drug development procedures. The book is designed to be of interest to research and development personnel in the pharmaceutical industry, including clinical and research pharmacists and pharmacologists, organic, medicinal, cosmetic, analytical, and clinical chemists and biochemists, clinical toxicologists, biostatisticians, government regulatory personnel, international pharmaceutical manufacturers and students in drug development courses.
Review:
..."a useful road map to understanding the requirements that a drug product must fulfill to achieve approval." Journal of Medicinal Chemistry "There are very useful formats, brochures, statistics, addresses and checklists provided...in order to have a clean picture of the entire drug approval process. "The book has accomplished the laborious task of obtaining about 600 indispensable acronyms.a must for researchers, libraries, project consultants and...regulatory personnel." Pharmaceutical Development and Technology
"About this title" may belong to another edition of this title.